Skip to content

Clinical trials

Phase 4 Hepatitis C trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 4 Country / region: United States Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20034
20042
20057
20061
20071
20083
20091
20103
20114
20123
20131
20144
20155
20166
20179
201810
20196
20203
20212
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated17
Withdrawn12
Unknown status4
Active, not recruiting2
Recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital8
Brooke Army Medical Center4
Johns Hopkins University4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
University of California, San Francisco4
University of Maryland, Baltimore4
National Institute of Allergy and Infectious Diseases (NIAID)3
Weill Medical College of Cornell University3
Mayo Clinic2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C84
Hepatitis C, Chronic12
Acquired Immunodeficiency Syndrome8
Fibrosis7
HIV Infections7
Liver Diseases6
Renal Insufficiency5
Kidney Failure, Chronic4
Renal Insufficiency, Chronic4
Anemia, Hemolytic3

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.